# The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients

> **NCT06503016** · PHASE3 · RECRUITING · sponsor: **Università Vita-Salute San Raffaele** · enrollment: 400 (estimated)

## Conditions studied

- Hypotension
- Consciousness, Level Altered
- Airway Disease
- Respiratory Failure
- Tachypnea
- Bradypnea
- Tachycardia
- Bradycardia
- Cardiac Failure
- Cardiac Arrest

## Interventions

- **DRUG:** Phosphocreatine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06503016
- **Lead sponsor:** Università Vita-Salute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-08
- **Primary completion:** 2026-04
- **Final completion:** 2026-07
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06503016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06503016, "The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06503016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*